Weighted Average Number of Shares Outstanding, Basic of VERTEX PHARMACEUTICALS INC / MA from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • VERTEX PHARMACEUTICALS INC / MA Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 255,700,000, a 0.85% decline year-over-year.
  • VERTEX PHARMACEUTICALS INC / MA annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 255,700,000, a 0.85% decline from 2024.
  • VERTEX PHARMACEUTICALS INC / MA annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 257,900,000, a 0.08% increase from 2023.
  • VERTEX PHARMACEUTICALS INC / MA annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 257,700,000, a 0.62% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 255,700,000 -2,200,000 -0.85% 01 Oct 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 255,600,000 -2,400,000 -0.93% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 256,700,000 -1,400,000 -0.54% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 256,900,000 -1,300,000 -0.5% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 257,900,000 +200,000 +0.08% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 258,000,000 0 0% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 258,100,000 +400,000 +0.16% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 258,200,000 +800,000 +0.31% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 257,700,000 +1,600,000 +0.62% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
Q3 2023 258,000,000 +1,500,000 +0.58% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 257,700,000 +1,800,000 +0.7% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 257,400,000 +2,300,000 +0.9% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 256,100,000 -1,600,000 -0.62% 01 Oct 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
Q3 2022 256,500,000 -1,400,000 -0.54% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 255,900,000 -3,100,000 -1.2% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 255,100,000 -4,300,000 -1.7% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 257,700,000 -2,338,000 -0.9% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
Q3 2021 257,900,000 -2,492,000 -0.96% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 259,000,000 -637,000 -0.24% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 259,400,000 -415,000 -0.16% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 260,038,000 +2,035,000 +0.79% 01 Oct 2020 31 Dec 2020 10-K 11 Feb 2021 2020 FY
Q3 2020 260,392,000 +3,446,000 +1.3% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 259,637,000 +3,483,000 +1.4% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 259,815,000 +4,120,000 +1.6% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 258,003,000 +3,135,000 +1.2% 01 Oct 2019 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 256,946,000 +2,041,000 +0.8% 01 Jul 2019 30 Sep 2019 10-K 11 Feb 2021 2020 FY
Q2 2019 256,154,000 +2,019,000 +0.79% 01 Apr 2019 30 Jun 2019 10-K 11 Feb 2021 2020 FY
Q1 2019 255,695,000 +2,464,000 +0.97% 01 Jan 2019 31 Mar 2019 10-K 11 Feb 2021 2020 FY
Q4 2018 254,868,000 +3,311,000 +1.3% 01 Oct 2018 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 254,905,000 +4,637,000 +1.9% 01 Jul 2018 30 Sep 2018 10-K 13 Feb 2020 2019 FY
Q2 2018 254,135,000 +6,614,000 +2.7% 01 Apr 2018 30 Jun 2018 10-K 13 Feb 2020 2019 FY
Q1 2018 253,231,000 +7,207,000 +2.9% 01 Jan 2018 31 Mar 2018 10-K 13 Feb 2020 2019 FY
Q4 2017 251,557,000 +6,103,000 +2.5% 01 Oct 2017 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q3 2017 250,268,000 +5,348,000 +2.2% 01 Jul 2017 30 Sep 2017 10-K 13 Feb 2019 2018 FY
Q2 2017 247,521,000 +3,039,000 +1.2% 01 Apr 2017 30 Jun 2017 10-K 13 Feb 2019 2018 FY
Q1 2017 246,024,000 +2,193,000 +0.9% 01 Jan 2017 31 Mar 2017 10-K 13 Feb 2019 2018 FY
Q4 2016 245,454,000 +4,142,000 +1.7% 01 Oct 2016 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q3 2016 244,920,000 +2,951,000 +1.2% 01 Jul 2016 30 Sep 2016 10-K 15 Feb 2018 2017 FY
Q2 2016 244,482,000 +3,725,000 +1.5% 01 Apr 2016 30 Jun 2016 10-K 15 Feb 2018 2017 FY
Q1 2016 243,831,000 +4,338,000 +1.8% 01 Jan 2016 31 Mar 2016 10-K 15 Feb 2018 2017 FY
Q4 2015 241,312,000 +6,005,000 +2.6% 01 Oct 2015 31 Dec 2015 10-K 15 Feb 2018 2017 FY
Q3 2015 241,969,000 +5,832,000 +2.5% 01 Jul 2015 30 Sep 2015 10-Q 31 Oct 2016 2016 Q3
Q2 2015 240,757,000 +6,949,000 +3% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2016 Q2
Q1 2015 239,493,000 +6,606,000 +2.8% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016 2016 Q1
Q4 2014 235,307,000 +4,043,000 +1.7% 01 Oct 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
Q3 2014 236,137,000 +5,632,000 +2.4% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015 2015 Q3
Q2 2014 233,808,000 +11,755,000 +5.3% 01 Apr 2014 30 Jun 2014 10-Q 04 Aug 2015 2015 Q2
Q1 2014 232,887,000 +17,466,000 +8.1% 01 Jan 2014 31 Mar 2014 10-Q 04 May 2015 2015 Q1
Q4 2013 231,264,000 +16,657,000 +7.8% 01 Oct 2013 31 Dec 2013 10-K 11 Feb 2014 2013 FY
Q3 2013 230,505,000 +16,738,000 +7.8% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 222,053,000 +10,709,000 +5.1% 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q1 2013 215,421,000 +7,403,000 +3.6% 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014 2014 Q1
Q4 2012 214,607,000 +7,849,000 +3.8% 01 Oct 2012 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q3 2012 213,767,000 +7,765,000 +3.8% 01 Jul 2012 30 Sep 2012 10-K 11 Feb 2014 2013 FY
Q2 2012 211,344,000 +6,931,000 +3.4% 01 Apr 2012 30 Jun 2012 10-K 11 Feb 2014 2013 FY
Q1 2012 208,018,000 +5,689,000 +2.8% 01 Jan 2012 31 Mar 2012 10-K 11 Feb 2014 2013 FY
Q4 2011 206,758,000 +5,403,000 +2.7% 01 Oct 2011 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 206,002,000 +5,115,000 +2.5% 01 Jul 2011 30 Sep 2011 10-K 01 Mar 2013 2012 FY
Q2 2011 204,413,000 +4,016,000 +2% 01 Apr 2011 30 Jun 2011 10-K 01 Mar 2013 2012 FY
Q1 2011 202,329,000 +3,394,000 +1.7% 01 Jan 2011 31 Mar 2011 10-K 01 Mar 2013 2012 FY
Q4 2010 201,355,000 01 Oct 2010 31 Dec 2010 10-K 22 Feb 2012 2011 FY
Q3 2010 200,887,000 01 Jul 2010 30 Sep 2010 10-K 22 Feb 2012 2011 FY
Q2 2010 200,397,000 01 Apr 2010 30 Jun 2010 10-K 22 Feb 2012 2011 FY
Q1 2010 198,935,000 01 Jan 2010 31 Mar 2010 10-K 22 Feb 2012 2011 FY

VERTEX PHARMACEUTICALS INC / MA Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 255,700,000 -2,200,000 -0.85% 01 Jan 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
2024 257,900,000 +200,000 +0.08% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
2023 257,700,000 +1,600,000 +0.62% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
2022 256,100,000 -1,600,000 -0.62% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2021 257,700,000 -2,100,000 -0.81% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
2020 259,800,000 +3,100,000 +1.2% 01 Jan 2020 31 Dec 2020 10-K 10 Feb 2023 2022 FY
2019 256,700,000 +2,408,000 +0.95% 01 Jan 2019 31 Dec 2019 10-K 09 Feb 2022 2021 FY
2018 254,292,000 +5,434,000 +2.2% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021 2020 FY
2017 248,858,000 +4,173,000 +1.7% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
2016 244,685,000 +3,373,000 +1.4% 01 Jan 2016 31 Dec 2016 10-K 13 Feb 2019 2018 FY
2015 241,312,000 +6,005,000 +2.6% 01 Jan 2015 31 Dec 2015 10-K 15 Feb 2018 2017 FY
2014 235,307,000 +10,401,000 +4.6% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
2013 224,906,000 +12,960,000 +6.1% 01 Jan 2013 31 Dec 2013 10-K 16 Feb 2016 2015 FY
2012 211,946,000 +7,055,000 +3.4% 01 Jan 2012 31 Dec 2012 10-K 13 Feb 2015 2014 FY
2011 204,891,000 +4,489,000 +2.2% 01 Jan 2011 31 Dec 2011 10-K 11 Feb 2014 2013 FY
2010 200,402,000 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.